Search Results 371-380 of 23953 for Ovary
... ovarian response to controlled ovarian stimulation in women presenting ... Women with polycystic ovary syndrome (PCOS) have traditionally been treated ...
Chemotherapy Toxicity On Quality of Life in Older Patients with Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or ...
Radiation therapy aimed at the ovaries. Treatments to stop ovarian function may allow those who haven't been through menopause to take medicines only available ...
... ovarian cancer, where the disease is confined to the ovary, is more likely to be treated successfully. Vaginal cancer. Vaginal cancer most commonly occurs in ...
Current screening protocols fail to catch a notable number of people carrying genetic mutations associated with hereditary breast and ovarian cancer ...
The review of health records from 1980 to 2002 involved women who underwent removal of the uterus but not the ovaries. The study, which used data from the ...
... ovarian, fallopian tube, or primary peritoneal cancer or recurrent carcinosarcoma of the ovary. Patients with high-grade mixed histology are also eligible ...
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302) — Mayo Clinic. · Noninvasive detection of cancer. · Gynecologic cancer ...
His specific areas of clinical focus include: Personalized cancer therapy using ovarian cancer patient-derived xenografts (PDXs), also known as Cancer Avatars, ...
The drug used for HIPEC will be carboplatin, a Food and Drug Administration (FDA) approved drug for use in ovarian, fallopian tube or primary peritoneal cancer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.